PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding. Vanderlinden E, Boonen A, Noppen S, Schoofs G, et al. Antiviral Res 2023;217:105700.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vanderlinden E, Boonen A, Noppen S, Schoofs G, et al. PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding. Antiviral Res 2023;217:105700.
PMID: 37562608